Fig. 2From: Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a reviewNeuropsychiatric adverse events occurring with high-dose tafenoquine monotherapy or chloroquine/primaquine versus P. vivax parasitaemia [80]Back to article page